A unified context model : Bringing probabilistic models to context ontologyBINH AN TRUONG; LEE, Youngkoo; SUNG YOUNG LEE et al.Lecture notes in computer science. 2005, pp 566-575, issn 0302-9743, isbn 3-540-30803-2, 1Vol, 10 p.Conference Paper

The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancerHAN, Ji-Youn; BYUNG GIL CHOI; JI YOUNG CHOI et al.Lung cancer. 2006, Vol 54, Num 2, pp 227-234, issn 0169-5002, 8 p.Article

Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancerHAN, Ji-Youn; LIM, Hyeong-Seok; YONG HOON PARK et al.Lung cancer. 2009, Vol 63, Num 1, pp 115-120, issn 0169-5002, 6 p.Article

Association of p53 Codon 72 Polymorphism and MDM2 SNP309 With Clinical Outcome of Advanced Nonsmall Cell Lung CancerHAN, Ji-Youn; GEON KOOK LEE; DAE HO JANG et al.Cancer. 2008, Vol 113, Num 4, pp 799-807, issn 0008-543X, 9 p.Article

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with lrinotecan -pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancerHAN, Ji-Youn; LIM, Hyeong-Seok; YOO, Yeon-Kyeong et al.Cancer. 2007, Vol 110, Num 1, pp 138-147, issn 0008-543X, 10 p.Article

A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naive patients with metastatic or recurrent squamous cell carcinoma of the esophagusDAE HO LEE; HEUNG TAE KIM; HAN, Ji-Youn et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 1, pp 83-88, issn 0344-5704, 6 p.Article

Randomized Phase 2 Study of Irinotecan Plus Cisplatin Versus Gemcitabine Plus Vinorelbine as First-line Chemotherapy With Second-line Crossover in Patients With Advanced Nonsmall Cell Lung CancerHAN, Ji-Youn; DAE HO LEE; JUNG EUN SONG et al.Cancer. 2008, Vol 113, Num 2, pp 388-395, issn 0008-543X, 8 p.Article

Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinomaHAN, Ji-Youn; DAE HO LEE; SUNG YOUNG LEE et al.Cancer. 2005, Vol 104, Num 12, pp 2759-2765, issn 0008-543X, 7 p.Article

Randomized phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinomaHAN, Ji-Youn; LIM, Hyeong-Seok; DAE HO LEE et al.Cancer. 2006, Vol 106, Num 4, pp 873-880, issn 0008-543X, 8 p.Article

A novel multi-channel field effect transistor (McFET) on bulk Si for high performance sub-80nm applicationSUNG MIN KIM; EUN JUNG YOON; JEONG DONG CHOE et al.International Electron Devices Meeting. 2004, pp 639-642, isbn 0-7803-8684-1, 1Vol, 4 p.Conference Paper

A Phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinomaHAN, Ji-Youn; DAE HO LEE; HAE YOUNG KIM et al.Cancer. 2003, Vol 98, Num 9, pp 1918-1924, issn 0008-543X, 7 p.Article